Omalizumab for the Treatment of Multiple Food AllergiesRobert A. Wood, R. Sharon Chinthrajah, Ahmar Iqbal et al.|New England Journal of Medicine|2024Cited by 298
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ. Andrew Bird, A. Wesley Burks, Jonathan M. Spergel et al.|The Journal of Allergy and Clinical Immunology In Practice|2017Cited by 200
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P. Vickery, Dareen Siri, Andrea Vereda et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 89
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Christian Vogelberg, Deborah Albright et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 14
Shared Genetic Etiology Between Eoe and Other Allergic DiseasesLeah C. Kottyan, Marc E. Rothenberg, Joelle A. Rothenberg et al.|Journal of Allergy and Clinical Immunology|2015Cited by 1